Company Search:
Advanced Search
Sponsored Links
Shire Plc - adr - ADR Company Snapshot
Shire Plc - adr operates within the Pharmaceutical preparations sector. In addition to historical fundamental analyses, the complete report available to purchase compares Shire Plc - adr with three other companies in this sector in the United States: Perrigo Company PLC (2015 sales of $5.54 billion of which 50% was Consumer Healthcare), Eisai Company Limited ($4.97 billion of which 93% was Pharmaceutical Business), and Zoetis Inc ($4.77 billion of which 50% was International).

Sales Analysis. During the year ended December of 2015, sales at Shire Plc - adr were $6.42 billion. This is an increase of 6.6% versus 2014, when the company's sales were $6.02 billion. This was the fifth consecutive year of sales increases at Shire Plc - adr (and since 2010, sales have increased a total of 86%).
  Stock Performance Chart for Shire Plc - adr - ADR
  Stock Data: Recent Stock Performance:
  Current Price (1/13/2017): 170.22
(Figures in U.S. Dollars)
1 Week -5.5%   13 Weeks -1.1%  
4 Weeks -9.3%   52 Weeks -4.1%  
Shire Plc - adr - ADR Key Data:
  Ticker: SHPG Country: United States
  Exchanges: NAS Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Pharmaceutical Preparations
  2015 Sales 6,416,679,392
(Year Ending Jan 2016).
Employees: 5,548
  Currency: U.S. Dollars Market Cap: 51,684,466,000
  Fiscal Yr Ends: December Shares Outstanding: 303,633,333
  Share Type: Ordinary Closely Held Shares: 148,529
Sponsored Links
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.